Catalyst Wire Dossier Catalyst Wire Dossier

Mitapivat

mitapivat · Agios Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

12 regulatory and trial events tracked for Mitapivat, covering 2021-11-15 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Long-term Mitapivat Dosing in Subjects With Stable Sickle Cell Disease: An Extension of a Phase I Pilot Study of Mitapivat [Phase 1, Phase 2]

See pricing